These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21943846)

  • 41. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
    Tudó G; González J; Obama R; Rodríguez JM; Franco JR; Espasa M; Simarro PR; Escaramís G; Ascaso C; García A; Jiménez de Anta MT
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):15-22. PubMed ID: 14974741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
    Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002.
    Dewan P; Sosnovskaja A; Thomsen V; Cicenaite J; Laserson K; Johansen I; Davidaviciene E; Wells C
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):170-4. PubMed ID: 15732736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence, risk factors and resistance pattern.
    El-Sharif A; Afifi S; El-Dahshan R; Rafeh N; Eissa S
    Clin Microbiol Infect; 2012 Nov; 18(11):E438-45. PubMed ID: 22834638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
    Umubyeyi AN; Vandebriel G; Gasana M; Basinga P; Zawadi JP; Gatabazi J; Pauwels P; Nzabintwali F; Nyiramasarabwe L; Fissette K; Rigouts L; Struelens MJ; Portaels F
    Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G; Miörner H; Ahmed O; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidrug-resistant tuberculosis in central Asia.
    Cox HS; Orozco JD; Male R; Ruesch-Gerdes S; Falzon D; Small I; Doshetov D; Kebede Y; Aziz M
    Emerg Infect Dis; 2004 May; 10(5):865-72. PubMed ID: 15200821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The use of nationwide tuberculosis surveillance system data to determine geographical differences in drug resistance--consideration of the representativeness of the drug resistance rate in Japan].
    Ohmori M; Ito K; Uchimura K; Yamauchi Y; Shimouchi A; Yoshiyama T; Mitarai S; Ishikawa N
    Kekkaku; 2011 Jul; 86(7):729-35. PubMed ID: 21922783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First national survey of Mycobacterium tuberculosis drug resistance, Madagascar, 2005-2006.
    Ramarokoto H; Ratsirahonana O; Soares JL; Ravaosolo J; Ravololonandriana P; Rakotoarisaonina A; Ranjalahy G; Ranaivohajaina S; Mosa M; Robinson R; Ratsitorahina M; Rasolofo V; Rarivoson B
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):745-50. PubMed ID: 20487614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug resistance among tuberculosis patients, New York City, 1991 and 1992.
    Driver CR; Frieden TR; Bloch AB; Onorato IM
    Public Health Rep; 1994; 109(5):632-6. PubMed ID: 7938383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nationwide drug resistance survey of tuberculosis in the Philippines.
    Philippine Nationwide Tuberculosis Drug Resistance Survey Team
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):500-7. PubMed ID: 19335957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
    Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
    Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends.
    Huong NT; Lan NT; Cobelens FG; Duong BD; Co NV; Bosman MC; Kim SJ; van Soolingen D; Borgdorff MW
    J Infect Dis; 2006 Nov; 194(9):1226-32. PubMed ID: 17041848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
    Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.